Skip to main content

Table 3 mini-RQLQ scores by country and ARIA severity

From: Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey

 

Total

FF

MF

FP

 

N

Mean (SD)

N

Mean (SD)

N

β

95% CI

N

β

95% CI

Mini-RQLQ score

429

1.54 (1.06)

217

1.42 (1.04)

98

0.28

0.03 to 0.52

114

0.18

−0.05 to 0.41

Country sub-groups:

          

  France

155

1.35 (0.98)

79

1.25 (1.02)

33

0.46

0.09 to 0.83*

43

0.13

−0.22 to 0.48

  Germany

170

1.57 (0.97)

86

1.48 (0.98)

42

0.12

−0.25 to 0.48

42

0.17

−0.20 to 0.54

  Spain

104

1.75 (1.27)

52

1.57 (1.16)

23

0.08

−0.51 to 0.66

29

0.06

−0.50 to 0.63

Severity sub-groups:

          

  Mild intermittent

52

0.89 (0.80)

28

0.92 (0.89)

9

−0.01

−0.71 to 0.69

15

−0.21

−0.83 to 0.40

  Moderate/severe intermittent

143

1.41 (0.98)

78

1.35 (1.01)

37

0.09

−0.28 to 0.46

28

0.24

−0.18 to 0.65

  Moderate/severe persistent

234

1.76 (1.09)

111

1.59 (1.06)

52

0.45

0.09 to 0.81*

71

0.22

−0.11 to 0.55

  1. FF: Fluticasone furoate; FP: Fluticasone propionate; MF: Mometasone furoate; β = adjusted mean difference from FF.
  2. *p<0.05 (Bonferroni correction applied).